Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Acute Effect of Aclidinium on Hyperinflation and Lung Volume Distribution in Severe COPD Patients

Trial Profile

Acute Effect of Aclidinium on Hyperinflation and Lung Volume Distribution in Severe COPD Patients

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 15 May 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Aclidinium bromide (Primary) ; Glycopyrrolate (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 18 Sep 2014 Planned number of patients changed from 46 to 37 as per ClinicalTrials.gov record.
    • 08 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top